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Incidental findings on imaging
Common, potentially harmful, and important information for patients considering tests
Thomas C Booth consultant diagnostic and interventional neuroradiologist, and senior lecturer in
neuroimaging
Department of Neuroradiology, King’s College Hospital NHS Foundation Trust, London, UK; School of Biomedical Engineering & Imaging Sciences,
King's College London, St Thomas’s Hospital, London, UK
As O’Sullivan and colleagues show in a linked article (doi:10.
1136/bmj.k2387),1 unexpected anomalies discovered during
imaging are common. However, they are also problematic.2-4
Even though most unexpected anomalies are unlikely to be
clinically relevant, often the clinician and patient want to
evaluate them further as both are unwilling to accept the
uncertainty that often surrounds the diagnosis and subsequent
clinical course of the anomaly.5
Occasionally such a discovery can be beneficial and even life
saving,6 but it can also be harmful. A suspicious lesion can lead
to lifelong follow-up, further imaging and appointments,
unwarranted treatment, and even radical surgery, only for the
finding to be ultimately innocuous.7 Furthermore, unexpected
anomalies can cause anxiety (for patients and clinicians) and
incur financial penalties, including implications about future
medical and life insurance.4 Such costs to individuals led to the
acronym “VOMIT” (victims of modern imaging technology),
described in 2003 in this journal.8 Since then there has been a
steady increase in the use of imaging, and now 82 magnetic
resonance imaging and 151 computed tomography examinations
are performed per 1000 population every year in the 11 highest
income countries.9 The associated increase in unexpected
anomalies discovered during imaging causes substantial
downstream effects within healthcare systems,10 or “SPEW”
(scans propagating exponential workloads).11
Although it can be argued that such harmful discoveries are
unintentional, the possibility of unexpected anomalies and their
potential for harm are well known.7 If we are to first do no harm,
we should change our mindset and start thinking of unexpected
anomalies as side effects of medical imaging, and seek fully
informed consent before going ahead.11 To aid this shared
decision making,4 O’Sullivan and colleagues are to be
commended for their scholarship in completing a Herculean
analysis of an entire literature on the prevalence of these
“incidentalomas.”1
As the authors describe, the challenge in pooling data is that
individual studies have widely varying patient characteristics
(and large differences in prevalence of incidentalomas between
different age groups), imaging protocols (some study protocols
are better than others at detecting incidentalomas), and
definitions of incidentaloma (in many studies the definitions
are not clear and normal variants are not prespecified).12 If
clinicians share these data with patients to inform consent for
imaging, both parties must proceed with caution and a clear
understanding of how these were derived.
The authors defined incidentaloma as “an imaging abnormality
in a healthy, asymptomatic patient or an imaging abnormality
in a symptomatic patient, where the abnormality is not
apparently related to the patient’s symptoms.”1 In the context
of radiological diagnostics perhaps a more useful definition of
incidentalomas is “those findings that are discovered by chance
which can potentially affect the health of an individual.”7 This
would include other potentially harmful lesions such as large
cerebral aneurysms in addition to the possible malignancies
reported by O’Sullivan and colleagues. A further benefit would
be that many normal variants, physiological features, or
clinically irrelevant lesions would be excluded from the
prevalence. The estimated prevalence of incidentaloma using
these two different definitions may differ by an order of
magnitude.12
While the prevalence of malignancy in incidentalomas is useful
for decision making, clinicians and patients should be aware
that malignant neoplasms in one organ system can sometimes
confer better survival than benign neoplasms in another. For
example, overall survival is worse for benign gliomas than it is
for thyroid malignancies.13 14 If benign gliomas, which transform
to malignant gliomas, were included in the malignancy rates
given in the linked paper, the prevalence of brain “malignancy”
among incidentalomas would increase by two orders of
magnitude.12 15 This information is important—although the
absolute numbers of benign gliomas are relatively small, their
incidental discovery turns lives upside down.
Although making a careful risk assessment with patients before
pursuing an investigation is a central part of every clinician’s
job, incentives that reward overactivity might confound this
optimal approach.7 16 Discussion about the prevalence of
incidentalomas before an imaging test is likely to be beneficial
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in many scenarios, particularly where clinicians are under
pressure to investigate.11
However, there are many evidence based guidelines that
recommend practical approaches to requesting imaging.17 Better
adherence to this guidance would also reduce the harmful
overdiagnosis of conditions that will never cause symptoms or
shorten a patient’s life.16
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